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CASE REPORT
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ABSTRACT
Malignant melanoma arising in the oral cavity is particularly rare. The clinical presentations of malignant
melanoma can range from a benign-looking pigmented macule or nodule to a non-pigmented neoplasm which can
be categorized into primary or metastatic lesions. Less than 2% of all melanomas show no pigmentation and could
lead to misdiagnosis. Objective: To present a benign looking but life-threatening malignancy of melanotic
melanoma. Case report: A 59-year-old female patient was referred to a regional hospital for further treatment
of a localized gingival swelling with no ulceration at the anterior maxilla. An incisional biopsy was performed,
with initial histopathologic result of a peripheral giant cell granuloma. CT images demonstrated a locally invasive
bone destruction compromising the buccal cortical plate. The second biopsy revealed a non- demarcated mass
consisting of spindle-shaped to ovoid cells of variable sizes, shapes and staining characteristics, forming
short fascicles of various directions in hyalinized and myxoid stroma with focal areas of necrosis, bone invasion
and infiltration of vascular wall. The tumor cells strongly expressed Vimentin, S-100, HMB-45 and Melan-A and
the diagnosis of amelanotic melanoma was finally made. Conclusion: Oral amelanotic melanoma is extremely
rare and difficult to diagnose because of the absence of melanin pigment. Immunohistochemistry is a significant
tool being used to establish the correct diagnosis.
Key words: amelanotic melanoma, malignant melanoma, peripheral giant cell granuloma
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INTRODUCTION

rized into primary or metastatic lesions. The clinical appearance of the tumor is variable and may be classified
into the following 5 types: I-pigmented nodular type,
II-non-pigmented nodular type, III-pigmented macular
type, IV-pigmented mixed type, and V- non-pigmented
mixed type.2,5,6 Less than 2% of all melanomas show no
pigmentation. However, up to 75% of oral melanoma
are amelanotic.2 Primary amelanotic or non-pigmented
melanoma is a variant of mucosal melanoma which is
more difficult to diagnose than that of pigmented lesions
because of its benign-looking.3

Melanoma is a malignant neoplasm of melanocytes
which usually seen on the skin more than the mucosa.1
Mucosal melanomas are most frequently found in the
head and neck region, approximately more than 50% in
the oral cavity.1,2 However, malignant melanoma arising
in the oral cavity is particularly rare, accounting for less
than 1% of all melanomas1,3, and the most frequently
affected sites are the hard palate and the gingiva.2,4
Patients with mucosal melanomas of the oral cavity
often are asymptomatic, presenting high incidence in
the 5th to 8th decade of life. Male may be slightly more
affected than female.2,4

As generally known, the prognosis of mucosal
melanoma is poor due to its vertical growth pattern.
An overall 5-year survival rate is approximate 15%.2,7
Furthermore, the prognosis of amelanotic melanoma
is poorer than the pigmented type because it tends to
locally invade the surrounding tissue and metastasize.5

The clinical presentations of malignant melanoma can
range from a benign-looking pigmented macule or nodule to a non-pigmented neoplasm which can be catego175
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CASE REPORT
A 59-year-old female patient was referred from a rural
hospital for further treatment of a localized gingival
swelling without pain or paresthesia at the anterior
maxilla for 6 months. Teeth 11 and 21 were mobile and
finally extracted. An incisional biopsy was performed
on this lesion and the histopathologic examination was
initially reported as a peripheral giant cell granuloma.
One month later, she noticed that the lesion was
getting bigger, and bleeding occurred when chewing
or biting food. The patient was then referred to referral
Saraburi Regional Hospital for further investigation
and excisional biopsy. Gross specimen was sent to Oral
Pathology Laboratory, Faculty of Dentistry, Khon Kaen
University for further histopathologic investigation and
diagnosis.
Clinical presentation
Extraoral examination demonstrated a mild swelling at
the base of nose shallowing bilateral nasolabial folds.
Intraoral examination demonstrated a gingival swelling
at anterior maxilla from buccal gingiva to vestibular
area of 13-23. The lesion is slightly red, having smooth
surface and no exudation. Teeth 11 and 21 were
extracted due to severe tooth mobility, and there were
some residual blood spots observed on the soft palate
as a result of hard food chewing (Figure 1).

Figure 1. (A,B) Extraoral examination demonstrated a
mild swelling at the base of nose (arrows); (C) Intraoral
examination demonstrated a swelling with no ulceration at
buccal vestibule area of 13-23 (outline), and residual blood
spots at the posterior soft palate as a result of hard food
chewing was observed (arrow).

Radiographic examination
OPG demonstrated locally bone destruction in the
periradicular area of 15-24 to the hard palate. CT
images demonstrated a locally invasive bone destruction
compromising the buccal cortical plate (Figure 2).

A panel of immunohistochemical stainings was
established by using the following diagram (Figure 4).8
The first panel of immunohistochemical staining
demonstrated that these tumor cell strongly expressed
Vimentin and S-100 whereas AE1/AE3, CD34,
CD99, SMA showed either negative or weak staining.
The second panel of immunohistochemical staining
demonstrated that all neoplastic cells were strongly
positive for S-100. The ovoid cells were also positive
for HMB-45 and Melan A. Other stains including AE1/
AE3 and EMA were negative.

Histopathologic examination
The second biopsy was then performed at the referral
center and revealed a piece of soft tissue lined by
parakeratinized stratified squamous epithelium. The
underlying connective tissue demonstrated a nondermarcated mass consisting of spindle-shaped to
ovoid cells forming short fascicles of various directions
in hyalinized and myxoid stroma. These tumour cells
showed ovoid to round nuclei with small nucleoli and
amphophilic to eosinophilic cytoplasm. They were
variable in size, shape and staining characteristics.
Hyperchromatism and frequent mitoses are noted.
Focal areas of necrosis, bone invasion and infiltration
of vascular wall were also observed (Figure 3).

In conclusion, the panels of immunohistochemical
staining showed that these tumor cells strongly
expressed Vimentin, S-100, HMB-45 and Melan-A.
The diagnosis of amelanotic melanoma was finally
made (Figure 5).
Management
In the present case, there was no primary occult tumour
at other sites. The tumour was originated in the oral
cavity. Two months after the pathological diagnosis
was reported, the patient was referred to the Oral and
Maxillofacial Surgery Division for surgical resection
(including a partial maxillectomy and bilateral selective
neck dissection level I-IV), and reconstruction with
obturator under GA. The histopathologic result of
cervical lymph node revealed that one metastatic node
was detected.

Histopathological differential diagnosis
The histopathological examination revealed sheets of
spindle-shaped to ovoid cells, large and hyperchromatic
nuclei with numerous mitotic figures. These histological
features were consistent with a spindle cell malignancy.
The histopathological differential diagnosis for this
case included several mesenchymal tumours such as
neural tumours, vascular tumours, fibroblastic and
myofibroblastic tumours, muscular tumours, and some
epithelial tumours.
176
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melanoma is a relatively rare malignant tumour which
can be found in oral cavity comprising 2% to 8% of all
malignant melanomas. The hard palate and the gingiva
are the most common sites.3 The etiologic factors of
disease are still not well known.9 The incidence of the
disease is commonly high in the patient older than
40-year.2,10
Pigmented mucosal melanoma can be diagnosed clinically following visual signs of melanoma (A-B-C-D-E):
A-Asymmetry, B-Border irregularity, C- Color variation, D-Diameter (> 6mm) or Dark, and E-Evolving in
size, shape, color or elevation of the lesion. 2 However,
the diagnosis of amelanotic melanoma is more difficult
than those of pigmented types, and challenges the pathologists due to lack of pigmentation. The surface of
the lesion may be smooth which can mislead the clinician to diagnose it as a benign tumour such as pyogenic
granuloma.

Figure 2. (A) OPG demonstrated locally well-defined
margin radiolucency with no sclerotic border surrounding
the periapical area of 15-24 and involving the hard palate;
(B) CT coronal view demonstrated periradicular and palatal
bone destruction; (C,D) CT axial view demonstrated a soft
tissue mass arising in the anterior maxilla destroying buccal
bone through palatal bone.

10x

The histopathological examination of amelanotic melanoma reveals a several of spindle-shaped to ovoid cell
with large nuclei, mitotic figures and hyperchromatism.
No melanin pigment is observed in cytoplasm.2,3

40x

Histological differential diagnoses include spindle cell
malignancies of mesenchymal tissue, lymphoma, amelanotic melanoma, and undifferentiated carcinoma.3 Then,
the immunohistochemistry is useful for establishing the
correct diagnosis.

Figure 3. (A) Sections showed numerous spindle-shaped
to ovoid cells forming short fascicles of various directions
in hyalinized and myxoid stroma; (B) The tumour cells
demonstrated ovoid to round nuclei in various sizes with
small nucleoli. Hyperchromatism and mitoses are observed
(circles)(B).

Anti-S-100, anti-HMB-45 and anti-Melan-A are the most
commonly used antibodies for the immunohistochemical
diagnosis of primary oral melanoma.1,2,4,6 S-100 protein
is an acidic, calcium‐binding protein that is first
extracted from bovine brain by Moore in 1965.11 It is
a very sensitive marker to nevus and melanoma cells,
and can be used only a screening marker for melanomas
because of low specificity.4,11 S-100 protein has been
shown to be present in a wide range of tumors, such
as peripheral nerve sheath and cartilaginous tumors,
chordomas, Langerhans cell, and carcinomas from
various sites including the salivary gland, lung, breast,
stomach, colon, endometrium, kidney, and ovary.11
Anti‐HMB‐45, which was first described by Gown
et al.12 in 1986, is an antibody that recognizes the
melanosomal glycoprotein gp100.11 Anti‐HMB‐45
is regarded more specific but less sensitive than
S‐100 protein. It is very helpful in distinguishing the
differentiated melanomas from other non‐melanocytic
malignancies.4,11

Figure 5. The tumour cells showed positive immunohistochemical staining for HMB-45 (A) and Melan-A (B).

Melan‐A is another melanocytic differentiation marker
that is identified on melanomas as an antigenic target
of cytotoxic T lymphocytes. 11 Prasad et.al studied
about melanocytic differentiation markers in malignant
melanoma, and reported all of melanoma cases positive
to Melan-A. 13 In addition, most studies revealed
that Melan-A was higher sensitive and specific to
melanomas than S-100 and HMB-45.6

DISCUSSION
Amelanotic melanoma is a subtype of melanomas which
does not produce melanin pigment. It can be primary,
recurrent, or metastastic. Primary oral amelanotic
177
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Figure 4. The diagram demonstrated the diagnostic workflow of spindle cell neoplasms from mucosal based sites in the head
and neck

Vimentin, also known as fibroblast intermediate filament,
is the major intermediate filament found in non- muscle
cells. These cell types include fibroblast, endothelial
cells, macrophages, lymphocytes, Schwann cells,
and melanocytes. Mesenchymal and endothelial cells
usually stain vimentin positive and thus act as a measure
of internal quality control in immunoreactivity.14 In
the present case, immunohistochemical staining with
antibodies against the S-100, Vimentin, HMB-45,
and Melan-A proteins successfully diagnosed this
amelanotic case.

Vimentin were used for screening the origin of the
tumour cell. After that, HMB-45 and Melan-A were
used to confirm the diagnosis. Unfortunately, the patient
in this case report died six months after surgery.

CONCLUSION
In summary, oral amelanotic melanoma is extremely
rare and difficult to diagnose because of the absence of
melanin pigment. Immunohistochemistry is a significant
tool being used to establish the correct diagnosis.
However, early detection is the most important thing
which can lead the patient have the treatment earlier
and better outcome.

The prognosis of oral melanoma is relatively poor
but its amelanotic variant has even worse prognosis
because it exhibits a more aggressive biology and
because of difficulty in diagnosis which leads to delayed
treatment.2,15
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